Old Dominion Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Old Dominion Capital Management's BMY Position: Q3 2021 in Review
Old Dominion Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.62% in Q3 2021, buying an estimated $3.69K and bringing the position to 9,076 shares worth $537K. The position accounts for 0.11% of the portfolio, ranked #113.
Old Dominion Capital Management first reported a position in BMY in Q3 2018 and has held it in 13 quarters since. The position peaked at $603K in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Old Dominion Capital Management held 9,076 shares of Bristol-Myers Squibb worth $537K as of Q3 2021.
- Old Dominion Capital Management bought 56 Bristol-Myers Squibb shares in Q3 2021, an estimated $3.69K.
- Bristol-Myers Squibb made up 0.11% of Old Dominion Capital Management's portfolio in Q3 2021, its #113 holding.
- Old Dominion Capital Management first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 13 quarters since.
- Old Dominion Capital Management's Bristol-Myers Squibb position peaked at $603K in Q2 2021.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.